Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Nov 14;39(1):151–159. doi: 10.3892/or.2017.6097

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Aoto et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Figure 5. — Correlation of the number of CD8⁺ T cells before and after NAC with the HMGB1 and calreticulin score, and patient survival in breast cancer patients. (A) Evaluation of the number of CD8⁺ T cells before and after NAC. Representative IHC of CD8 is shown. (B) Evaluation of the number of CD8⁺ T cells before and after NAC in pathological response. (C) Correlation of the HMGB1/calreticulin score with the number of CD8⁺ T cells before and after NAC. (D) Correlation of the degree of infiltrating CD8⁺ T cells before and after NAC with clinical outcomes. *p<0.05. HMGB1, high-mobility group box 1 protein; NAC, neoadjuvant chemotherapy. n.s. not significant.